TOP TIERMARKET NEWSWIRE

News & sentiment

IBIO INC (IBIO) — News & AI sentiment

IBIO INC (IBIO) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 55.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

6

avg sentiment 55.8/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

IBIO news in the last 24 hours, 7 days, 30 days and 90 days

How much IBIO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	IBIO stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	6	55.8/100	IBIO headlines →
Last 90 days	15	52.1/100	IBIO headlines →

Latest stories on IBIO

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Oct 19

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Oct 13

iBio presents IBIO-610 data from obese non-human primate study

The Fly58 · neutralproduct/pr

Oct 13

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

GlobeNewswire64 · neutralproduct/pr

Oct 13

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

Business Insider63 · neutralproduct/pr

Oct 13

iBio, Inc. (IBIO) Presents at 2026 EASD Annual Meeting - Slideshow

Seeking Alpha50 · neutralgeneral

Oct 7

iBio stock initiated at buy by H.C. Wainwright with $7 target

Investing.com Analyst Ratings56 · neutralanalyst

Sep 17

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Sep 14

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

Business Insider56 · neutralgeneral

Sep 1

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Aug 28

iBio GAAP EPS of -$0.32 in-line, revenue of $0.1M misses by $0.04M

Seeking Alpha34 · bearishearnings

Aug 28

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

GlobeNewswire50 · neutralgeneral

Aug 28

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Business Insider50 · neutralgeneral

Aug 28

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style?

The Motley Fool50 · neutralgeneral

Aug 12

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Aug 4

iBio Updates Governance Deadlines for 2026 Annual Meeting

TipRanks50 · neutralgeneral

Jul 17

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Jul 17

iBio Highlights Promising New Preclinical Obesity Antibody Data

TipRanks63 · neutralproduct/pr

Jul 1

iBio, Inc. (IBIO) files 8-K

SEC 8-K50 · neutralgeneral

Jul 1

iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study | IBIO Stock News

StockTitan67 · bullishproduct/pr

Jul 1

Could iBio (IBIO) Be an Underrated Obesity Stock?

Yahoo Top63 · neutralanalyst

Jun 12

iBio to Participate in Upcoming Healthcare Investor Conferences | IBIO Stock News

StockTitan57 · neutralproduct/pr

Jun 2

iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity | IBIO Stock News

StockTitan63 · neutralproduct/pr

Jun 2

Open IBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →